Genetic profiling-based prognostic prediction of patients with advanced small-cell lung cancer in large scale analysis

Small-cell lung cancer (SCLC) accounts for approximately 13% of all newly diagnosed lung cancer patients, [1] and it is an exceptionally aggressive malignancy with a high proliferative index and an unusually strong predilection for early metastasis. [2] Despite extensive basic and clinical research over the past 30 years, little progress has been made in treating this disease. [2,3]

Source: Lung Cancer - November 12, 2018 Category: Cancer & Oncology Authors: Hibiki Udagawa, Shigeki Umemura, Isao Murakami, Sachiyo Mimaki, Hideki Makinoshima, Genichiro Ishii, Tomohiro Miyoshi, Keisuke Kirita, Shingo Matsumoto, Kiyotaka Yoh, Seiji Niho, Katsuya Tsuchihara, Koichi Goto Source Type: research